Mumbai: Pharmaceutical major, Cadila Healthcare has reported robust figures for the third quarter of the financial year ending December 31, 2010. The company in a filing with the BSE has said that its consolidated net profit grew by 25.6% to Rs. 162 crore while its consolidated net sales rose to Rs 1,130 crore from Rs 960 crore, during the third quarter of FY’11. The company attributed the strong performance to its good show in both the domestic sales, which rose 17 per cent, as well as exports, which grew 20%.
The company’s shares, however, ended the day in red at Rs 766, down 1.15% on Tuesday.
For live chart: click here
No comments:
Post a Comment